Abstract
Technologies for engineering synthetic transcription factors have enabled many advances in medical and scientific research. In contrast to existing methods based on engineering of DNA-binding proteins, we created a Cas9-based transactivator that is targeted to DNA sequences by guide RNA molecules. Coexpression of this transactivator and combinations of guide RNAs in human cells induced specific expression of endogenous target genes, demonstrating a simple and versatile approach for RNA-guided gene activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Rebar, E.J. et al. Nat. Med. 8, 1427–1432 (2002).
Graslund, T., Li, X., Magnenat, L., Popkov, M. & Barbas, C.F. III . J. Biol. Chem. 280, 3707–3714 (2005).
Beltran, A. et al. Oncogene 26, 2791–2798 (2007).
Bartsevich, V.V., Miller, J.C., Case, C.C. & Pabo, C.O. Stem Cells 21, 632–637 (2003).
Bultmann, S. et al. Nucleic Acids Res. 40, 5368–5377 (2012).
Blancafort, P., Magnenat, L. & Barbas, C.F. III . Nat. Biotechnol. 21, 269–274 (2003).
Park, K.S. et al. Nat. Biotechnol. 21, 1208–1214 (2003).
Lohmueller, J.J., Armel, T.Z. & Silver, P.A. Nucleic Acids Res. 40, 5180–5187 (2012).
Li, Y., Moore, R., Guinn, M. & Bleris, L. Scientific Rep. 2, 897 (2012).
Beerli, R.R., Dreier, B. & Barbas, C.F. III. Proc. Natl. Acad. Sci. USA 97, 1495–1500 (2000).
Garg, A., Lohmueller, J.J., Silver, P.A. & Armel, T.Z. Nucleic Acids Res. 40, 7584–7595 (2012).
Beerli, R.R. & Barbas, C.F. III . Nat. Biotechnol. 20, 135–141 (2002).
Zhang, F. et al. Nat. Biotechnol. 29, 149–153 (2011).
Miller, J.C. et al. Nat. Biotechnol. 29, 143–148 (2011).
Jinek, M. et al. Science 337, 816–821 (2012).
Cong, L. et al. Science 339, 819–823 (2013).
Mali, P. et al. Science 339, 823–826 (2013).
Cho, S.W., Kim, S., Kim, J.M. & Kim, J.S. Nat. Biotechnol. 31, 230–232 (2013).
Jinek, M. et al. eLife 2, e00471 (2013).
Qi, L.S. et al. Cell 152, 1173–1183 (2013).
Gilbert, L.A. et al. Cell doi:10.1016/j.cell.2013.06.044 (9 July 2013).
Perez-Pinera, P. et al. Nat. Methods 10, 239–242 (2013).
Maeder, M.L. et al. Nat. Methods 10, 243–245 (2013).
de Groote, M.L., Verschure, P.J. & Rots, M.G. Nucleic Acids Res. 40, 10596–10613 (2012).
Adler, A.F. et al. Mol.Ther. Nucleic Acids 1, e32 (2012).
Beerli, R.R., Segal, D.J., Dreier, B. & Barbas, C.F. III . Proc. Natl. Acad. Sci. USA 95, 14628–14633 (1998).
Gertz, J. et al. Genome Res. 22, 134–141 (2012).
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S.L. Genome Biol. 10, R25 (2009).
Anders, S. & Huber, W. Genome Biol. 11, R106 (2010).
Acknowledgements
This work was supported by a US National Institutes of Health (NIH) Director's New Innovator Award (DP2OD008586), National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award (CBET-1151035), NIH R03AR061042, and an American Heart Association Scientist Development Grant (10SDG3060033) to C.A.G., and grants from the NIH to G.E.C. (U54HG004563), K.W.L. (EB015300 and HL109442), and F.G. (R01AR48852). K.A.G. and P.I.T. were supported by NSF Graduate Research Fellowships. L.R.P. was supported by an NIH Biotechnology Training Grant to the Duke Center for Biomolecular and Tissue Engineering (T32GM008555). D.G.O. was supported by a predoctoral fellowship from the American Heart Association. C. Grigsby (Duke University) provided the pABOL polymer used in MEF transfections.
Author information
Authors and Affiliations
Contributions
P.P., C.M.V., A.F.A., D.G.O., G.E.C., T.E.R. and C.A.G. designed experiments. P.P., D.D.K., C.M.V., A.F.A., A.M.K., L.R.P., P.I.T., K.A.G. and D.G.O. performed the experiments. P.P., D.D.K., C.M.V., A.F.A., A.M.K., L.R.P., P.I.T., K.A.G., D.G.O., K.W.L., F.G., G.E.C., T.E.R. and C.A.G. analyzed the data. P.P. and C.A.G. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–10, and Supplementary Tables 1 and 2 (PDF 1133 kb)
Rights and permissions
About this article
Cite this article
Perez-Pinera, P., Kocak, D., Vockley, C. et al. RNA-guided gene activation by CRISPR-Cas9–based transcription factors. Nat Methods 10, 973–976 (2013). https://doi.org/10.1038/nmeth.2600
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth.2600
This article is cited by
-
Genetically-engineered mouse models of small cell lung cancer: the next generation
Oncogene (2024)
-
Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery
Gene Therapy (2024)
-
Joint genotypic and phenotypic outcome modeling improves base editing variant effect quantification
Nature Genetics (2024)
-
Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases
Nature Biotechnology (2024)
-
CRISPR/Cas9: a powerful tool in colorectal cancer research
Journal of Experimental & Clinical Cancer Research (2023)